Importance of human papillomavirus vaccination leaflets focusing on the safety profile targeted pediatricians in Japan

Vaccine. 2022 Aug 12;40(34):5010-5015. doi: 10.1016/j.vaccine.2022.07.008. Epub 2022 Jul 13.

Abstract

Objectives: To investigate the association between providing leaflets to support pediatricians in explaining the safety of the human papillomavirus (HPV) vaccine and mother's decision to vaccinate their daughters in Japan.

Methods: In this cross-sectional study, we conducted a survey of mothers to evaluate the effect of leaflets that were created to support pediatricians in explaining the safety profile of the HPV vaccine. Mothers who provided consent for vaccination before receiving an explanation were excluded from the study. The primary outcome was the mother's decision to vaccinatetheir daughters with the HPV vaccine after receiving an explanation from pediatricians using our leaflets.

Results: Among 161 eligible mothers, 101 decided on HPV vaccination (decided group) and 60 did not (decided against group). There was no difference in the maternal background between the 2 groups. The decided group had a significantly more positive impression of the leaflets than the undecided group. In multivariable logistic regression analysis, a detailed explanation for possible adverse events and specific solutions to them was associated with the mother's decision to have their daughters vaccinated (odds ratio 2.35, 95% confidence interval 1.02-5.44), but not the pathology of cervical cancer and the HPV vaccination process.

Conclusion: Leaflets emphasizing an explanation of adverse events may contribute to mothers' decision making for HPV vaccination.

Keywords: Human papillomavirus; Leaflets; Pediatricians; Safety.

MeSH terms

  • Alphapapillomavirus*
  • Cross-Sectional Studies
  • Female
  • Health Knowledge, Attitudes, Practice
  • Humans
  • Japan
  • Mothers
  • Papillomavirus Infections* / prevention & control
  • Papillomavirus Vaccines* / adverse effects
  • Pediatricians
  • Surveys and Questionnaires
  • Uterine Cervical Neoplasms* / prevention & control
  • Vaccination

Substances

  • Papillomavirus Vaccines